-
ZIOPHARM Announces Clinical Data On Brain Cancer Drug
Thursday, November 17, 2016 - 10:01am | 319ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) is a biopharmaceutical company dedicated towards developing a portfolio of cancer therapies through synthetic immuno-oncology. Ziopharm announced Thursday an update related to an ongoing trial of its AD-RTS-hil-12 + orally-administered veledimex that's...